YES on the California Immunology Research & Cures Initiative

Advancing life-saving immunology and immunotherapy research for all Californians

The California Immunology Research & Cures Initiative on the November 2026 ballot will fund cutting-edge immunology and immunotherapy research to prevent and cure common diseases that impact millions of Californians, including cancers, heart disease, and Alzheimer's.

Key reasons to support the CA Immunology Research & Cures Initiative:

Provides critical funding for immunology research

Dedicated funding for cancer, Alzheimer's and heart disease research

Fosters collaboration between leading scientists and physicians

Mandates strong accountability and transparency

Bond funds and interest repaid to state

Requires 20% discount on medicines and cures for Californians

What are Immunology and Immunotherapies?

Immunology is the field of medical science focused on understanding the immune system and its role in preventing and treating diseases. By supporting immunology research and the development of innovative immunotherapies for diseases like cancer, Alzheimer’s, Parkinson's and heart disease, this initiative will provide significant benefits for California families.

Learn about Cures in our Lifetime

What Our Supporters Are Saying

  • "Blood Cancer United strongly supports the California Immunology Research & Cures Initiative. This measure will strengthen California’s research and clinical trial infrastructure, helping ensure patients can access cutting-edge therapies sooner while accelerating the search for cures."

    Adam Zarrin, Director of State Government Affairs
    Blood Cancer United
  • "The Parkinson Association of Northern California supports the California Immunology Research & Cures Initiative because it drives disease-modifying research focused on slowing or stopping Parkinson’s, and this measure holds real potential to save lives."

    Jan Whitney, Executive Director
    Parkinson Association of Northern California
  • "We stand at a threshold of exciting breakthroughs in treating intractable diseases. We need to support cure-finding research in immunology and immunotherapies."

    Steve A. Kay, Ph.D., D.Sc., FRS
    Steve A. Kay, Ph.D., D.Sc., FRS
    Professor and Director, University of Southern California; Member, National Academy of Sciences
  • "Having spent decades at the forefront of disease prevention, I understand the promise of vaccines, therapies and cures that come from immunology research. Supporting this bond is a vital step toward decoding the human immune system and accelerating the breakthroughs needed to end our most devastating diseases."

    Wayne Koff, Ph.D., Founding CEO
    Wayne Koff, Ph.D., Founding CEO
    Human Immunome Project
  • "We believe California should lead the nation in science funding and this measure is a prime example of how strategic investment can improve the health and outcomes of all Californians."

    Margaret Hitchcock, Ph.D., President
    California Colorectal Cancer Coalition
  • "As a physician-scientist who has spent my career developing vaccines and advancing global health, I know that immunology research is our most powerful tool for preventing and curing diseases ranging from cancer to Alzheimer’s. Investing in this bond will accelerate lifesaving discoveries, strengthen our preparedness for future health threats and deliver hope to millions of families."

    Dr. Peter Hotez, M.D., Ph.D.
    Dr. Peter Hotez, M.D., Ph.D.
    Pediatrician and Vaccine Scientist
  • "Immunotherapy saved my life — I was just weeks away from losing my life when a breakthrough treatment gave me a second chance. That’s why I’m proud to support this bond, because no one should be told hope is out of reach when we have the science to save them."

    Laurie Adami
    Laurie Adami
    Cancer Pioneer and Patient Advocate
  • "This measure is an important part of the equation to help close the gap in health outcomes for black Californians and other vulnerable communities."

    Rhonda Smith, Executive Director
    California Black Health Network
  • "The immune system holds one of the most promising pathways to curing diseases that have long evaded treatment. Major initiatives are needed to turn that emerging science into real-world solutions faster — bringing us closer to therapies that save lives."

    Elaine Y. Hsiao, Ph.D.
    Elaine Y. Hsiao, Ph.D.
    Professor & Leading Immunology and Brain Health Researcher
Titles and affiliations are for identification purposes only.

Join Our Growing Coalition Today

Signature gathering is happening now! Sign our petition today to help qualify our measure for the 2026 California statewide ballot.